The content on this page is being archived for historic and reference purposes only. The content, links, and pdfs are no longer maintained and might be outdated.
Perspectives in Disease Prevention and Health Promotion Summary of the Agency for Toxic Substances and Disease Registry Report to Congress: The Public Health Implications of Medical Waste
The Medical Waste Tracking Act of 1988* requires the administrator of the Agency for Toxic Substances and Disease Registry (ATSDR) to prepare a report on the health effects of medical waste**.*** To comply with the act, ATSDR obtained data from professional associations, unions, and environmental, academic, and industrial groups (1). The information and comments were collected during an extensive review process that involved an internal ATSDR panel; a federal advisory panel comprising representatives from Public Health Service (PHS) agencies, the Environmental Protection Agency, and the Health Care Financing Administration; an external peer review panel; public comments; and review by PHS and the Department of Health and Human Services. The findings were presented to Congress in The Public Health Implications of Medical Waste: A Report to Congress (2). This report summarizes the conclusions and recommendations in the ATSDR report.
The report presented estimates of the number of persons injured by sharps**** in medical waste, the number who may become infected with hepatitis B virus (HBV) and human immunodeficiency virus (HIV) as the result of medical waste-related sharp injuries, and the number who may develop hepatitis B and acquired immunodeficiency syndrome (AIDS) as the result of those injuries. (The number of other infections or infectious diseases related to medical waste could not be estimated because relevant data were not available.) These estimates are upper-limit theoretical estimates because the probability of infection is based on case studies of persons who came in contact with freshly drawn blood or other body fluids--an event more likely to occur during patient care than during medical-waste handling. In addition, some persons may be immune to HBV infection because of prior exposure or immunization (3). The estimates did not take into account the rapid decline of viable HIV outside a living host. Because data were not available to determine how many janitorial and laundry workers, laboratory workers, and building engineers are employed at nonhospital facilities that generate medical waste, estimates could not be derived for these workers in these settings.
Based on available estimates, a maximum of less than 1-4 AIDS cases per year ( less than 0.003%-0.01% of 33,173 AIDS cases in the United States reported to CDC in 1989 (4)) occur in health-care workers as a result of contact with medical waste sharps (Table 1). An estimated 80-160 hepatitis B cases per year may occur as a result of contact with medical waste sharps (0.05%-0.1% of 150,000 hepatitis B cases annually in the United States (5)).
Other findings included: blPersons without occupational exposure are not likely to be adversely affected by medical waste generated in the traditional health-care setting. blOutside the health-care setting, the potential for HBV or HIV infection in the general population following medical waste-related injuries is not likely to be a public health concern; however, needlestick injuries may cause local or systemic secondary infections. blIncreased in-home health care and other sources of nonregulated medical waste increase the likelihood that the general public may come in contact with medical waste.
The estimated numbers of medical waste-related HIV and HBV infections and cases are of public health concern for selected occupations involved with medical waste (e.g., janitorial and laundry workers, nurses, emergency medical personnel, and refuse workers).
The approximately 1.2 million U.S. intravenous-drug users (IVDUs) (6)--who have high rates of HIV and HBV infection--are a major source of discarded sharps. Although the general public may be at risk for injury and infection following contact with these discarded sharps, the potential risk for HIV and HBV infection from IVDU-related waste cannot be estimated.
The potential for infection resulting from contact with nonsharp medical waste is likely to be substantially less than that related to contact with medical waste sharps, since a portal of entry must exist before contact with nonsharp medical waste for infection or disease to occur.
Medical waste can be effectively treated by chemical, physical, or biologic means (e.g., chemical decontamination, autoclaving, incineration, irradiation, and sanitary sewage treatment). Medical waste does not contain any greater quantity or different type of microbiologic agents than residential waste. In addition, properly operated sanitary landfills provide microbiologic environments hostile to most pathogenic agents. Therefore, untreated medical waste can be disposed of in sanitary landfills if procedures to prevent worker contact with this waste during handling and disposal operations are strictly followed. Reported by: Medical Waste Group, Agency for Toxic Substances and Disease Registry.
Editorial Note: In general, medical waste generated in traditional health-care settings is not a health risk for the general public. However, general environmental degradation caused by medical waste poses public health and aesthetic concerns. Because of the special characteristics of medical waste as a solid waste, management systems must be developed for nonregulated medical waste; these systems must be environmentally safe and not jeopardize the public's health.
Of the 158 million tons of municipal solid waste created yearly nationwide, 0.3% is medical waste. The most effective way of reducing medical waste is to reduce the amount of waste created, on a small scale in homes and on a large scale in health-care operations. Simultaneously, the impetus to recycle, reuse, and reclaim products is essential to adequately manage medical waste and other solid wastes.
In 1988, 44 states had medical-waste regulations in place. Among those states, however, there were differences in the types of waste materials designated as medical waste and in their management and disposal. Some states (e.g., Washington) have conducted worker surveys to determine injury rates. Metropolitan areas such as New York City have conducted similar worker surveys of municipal trash collectors and medical waste trash collectors.
Copies of the ATSDR report can be obtained through the National Technical Information Service for $31, plus a $3 handling fee; telephone (703) 487-4650.
and stocks, pathologic wastes, blood and blood products, sharps, animal waste, selected isolation waste, and unused discarded sharps.
*** Section 11009 of the act specifies that the report must include 1) a description of the potential for infection or injury from the segregation, handling, storage, treatment, or disposal of medical wastes; 2) an estimate of the number of persons injured or infected annually by sharps in medical waste, and the nature and seriousness of those injuries or infections; 3) an estimate of the number of persons infected annually by other means related to waste segregation, handling, storage, treatment, or disposal, and the nature and seriousness of those infections; and 4) for diseases possibly spread by medical waste, including acquired immunodeficiency syndrome and hepatitis B, an estimate of what percentage of the total number of cases nationally may be traceable to medical wastes. **** Needles, scalpel blades, and other implements that could cause puncture wounds or other injuries.
Disclaimer All MMWR HTML documents published before January 1993 are electronic conversions from ASCII text into HTML. This conversion may have resulted in character translation or format errors in the HTML version. Users should not rely on this HTML document, but are referred to the original MMWR paper copy for the official text, figures, and tables. An original paper copy of this issue can be obtained from the Superintendent of Documents, U.S. Government Printing Office (GPO), Washington, DC 20402-9371; telephone: (202) 512-1800. Contact GPO for current prices.**Questions or messages regarding errors in formatting should be addressed to firstname.lastname@example.org.
Page converted: 08/05/98
This page last reviewed 5/2/01